Status:
NOT_YET_RECRUITING
Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Perinatal Opioid Use Disorder
Opioid Use Disorder
Eligibility:
FEMALE
Phase:
NA
Brief Summary
To address both loneliness and engagement in perinatal and OUD care among perinatal women, the investigators plan to adapt an existing texting support chatbot, Penny, to make it appropriate for use by...
Eligibility Criteria
Inclusion
- Biological females who are currently pregnant or within 6 weeks postpartum.
- Able to read, write, and speak English at a 6th grade level.
- Diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder.
- Receiving prenatal care and OUD care at a Penn affiliated hospital.
Exclusion
- Current untreated psychosis, mania, or active suicidality as assessed by the Mini International Neuropsychiatric Interview (MINI).
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06969261
Start Date
January 1 2026
End Date
June 30 2026
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104-3309